A compound of sulfonamides a pyrimidine between sodium injection, whose character is, by the following components described by a ratio of sulfonamides: a pyrimidine between sodium 5-20 copies naproxen, 0.5 4 a, 1-8 received a, a oxygen amine pyrimidine benzyl 1-3 copies, propylene glycol 30-65 copies, sulfur and sodium 0.05 0.3 a, DMF 5-20 copies.
This product is mainly used for sensitive bacteria cause infection, also can used for the pig toxoplasma disease.
Used in the treatment of:
1. The sensitive haemophilus influenzae, streptococcus pneumoniae, and other sensitive caused by the bacterium acute bronchitis, light disease pneumonia, enteritis.
2. The procedures of combination therapy pyrimidine rat caused by toxoplasma gondii toxoplasma disease.
Usage and dosage:
Muscle note or intravenous: once every 1 kg of weight, livestock 0.05 0.1 g. 2 times a day, or two to three days.
Properties: the product is colorless or small yellow transparent liquid, encounter light easy metamorphism.
Specification: 10 ml: 1.0 g.
The Centers for Disease Control estimate that each year in the United States, more than 2 million people are infected with an antibiotic-resistant infection. Melanie Harvey, Associate Professor of Chemistry, and Heather Seitz, Associate Professor of Biology, team up to present the current reality and future challenges of antibiotic resistance. They’ll discuss the history of antibiotics, the decline in the discovery of new antibiotics, causes of antibiotic resistance, steps the public can take to prevent antibiotic resistance, and the research being done to develop new antibiotics.
For more information on this and other happenings at the college, visit https://www.jccc.edu.